List of Queen Mary University of London patents

Patents where

Current Assignee

Name

Queen Mary University of London

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11531036 Method and apparatus for determining the efficacy of statins for treating inflammatory diseases in individual patients	Patent 11531036 was granted and assigned to Queen Mary University of London on December, 2022 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	11531036	December 20, 2022
‌ US Patent 9761210 Control methods for musical performance	Patent 9761210 was granted and assigned to Queen Mary University of London on September, 2017 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	9761210	September 12, 2017
‌ US Patent 9623005 Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions	Patent 9623005 was granted and assigned to Queen Mary University of London on April, 2017 by the United States Patent and Trademark Office.		Queen Mary University of London	United States Patent and Trademark Office	9623005	April 18, 2017
‌ US Patent 11578035 Chlorhexidine crystal forms and uses thereof in medicine	Patent 11578035 was granted and assigned to Queen Mary University of London on February, 2023 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	11578035	February 14, 2023
‌ US Patent 11415573 Diagnostics	Patent 11415573 was granted and assigned to Queen Mary University of London on August, 2022 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	11415573	August 16, 2022
‌ US Patent 11351209 Inhibitors of PI3K p-delta 110 for use in delivery of viruses in the treatment of cancer	Patent 11351209 was granted and assigned to Queen Mary University of London on June, 2022 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	11351209	June 7, 2022
‌ US Patent 9631172 Method for manufacturing a three-dimensional biomimetic scaffold and uses thereof	Patent 9631172 was granted and assigned to Queen Mary University of London on April, 2017 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	9631172	April 25, 2017
‌ US Patent 9845506 Method for determining prognosis of prostate cancer in a subject	Patent 9845506 was granted and assigned to Queen Mary University of London on December, 2017 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	9845506	December 19, 2017
‌ US Patent 9949948 Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions	Patent 9949948 was granted and assigned to Queen Mary University of London on April, 2018 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	9949948	April 24, 2018
‌ US Patent 9485578 Audio format	Patent 9485578 was granted and assigned to Queen Mary University of London on November, 2016 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	9485578	November 1, 2016
‌ US Patent 9863954 Methods for screening anti-protein aggregation agents using single-stranded specific RNAses to initiate protein aggregation	Patent 9863954 was granted and assigned to Queen Mary University of London on January, 2018 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	9863954	January 9, 2018
‌ US Patent 10766942 Fragments of syndecan-2 having anti-angiogenic activity		Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	10766942	September 8, 2020
‌ US Patent 10640463 Chlorhexidine crystal forms and uses thereof in medicine	Patent 10640463 was granted and assigned to Queen Mary University of London on May, 2020 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	10640463	May 5, 2020
‌ US Patent 10416159 Method for treating rheumatoid arthritis	Patent 10416159 was granted and assigned to Queen Mary University of London on September, 2019 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	10416159	September 17, 2019
‌ US Patent 10782301 Biomarkers for pancreatic cancer	Patent 10782301 was granted and assigned to Queen Mary University of London on September, 2020 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	10782301	September 22, 2020
‌ US Patent 10590188 Antibody	Patent 10590188 was granted and assigned to Queen Mary University of London on March, 2020 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	10590188	March 17, 2020
‌ US Patent 11690841 Glycolysis-activating agents for treatment or prevention of disease		Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	11690841	July 4, 2023
‌ US Patent 11977077 Biomarkers for pancreatic cancer	Patent 11977077 was granted and assigned to Queen Mary University of London on May, 2024 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	11977077	May 7, 2024
‌ US Patent 12023313 Method of treatment of obesity	Patent 12023313 was granted and assigned to Queen Mary University of London on July, 2024 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	12023313	July 2, 2024
‌ US Patent 11891652 Biosensor device and assembly methods	Patent 11891652 was granted and assigned to Queen Mary University of London on February, 2024 by the United States Patent and Trademark Office.	Queen Mary University of London	Queen Mary University of London	United States Patent and Trademark Office	11891652	February 6, 2024

20 results

0 selected

20 results

0 selected